AstraZeneca AB v. Sun Pharma Global FZE

Application Number	Patent Number	External Links
-	USRE44186	Espacenet Google Patents
-	US7951400	Espacenet Google Patents
-	US8628799	Espacenet Google Patents

COMPLAINT filed against Caraco Pharmaceutical Laboratories Ltd., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1525830.) - filed by AstraZeneca AB. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(dmp, ) (Entered: 06/03/2014)

2014-06-02

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 06/03/2014)

2014-06-02

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 4/25/14. Date of Expiration of Patent: See attached.Thirty Month Stay Deadline: 10/26/2016. (dmp, ) (Entered: 06/03/2014)

2014-06-02

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE44,186; 7,951,400; 8,628,799;. (dmp, ) (Entered: 06/03/2014)

2014-06-02

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC, Corporate Parent Zeneca Wilmington Inc. for AstraZeneca AB filed by AstraZeneca AB. (dmp, ) (Entered: 06/03/2014)

2014-06-02

1

View

No Summons Issued. (dmp, )

2014-06-02

1

No Actions

Summons Issued with Magistrate Consent Notice attached as to Caraco Pharmaceutical Laboratories Ltd. on 6/3/2014; Sun Pharma Global FZE on 6/3/2014. (rwc)

2014-06-03

1

No Actions

Summons Reissued with Magistrate Consent Notice attached as to Sun Pharma Global FZE. (rbe)

2014-06-04

1

No Actions

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:14-cv-00694-GMS, 1:14-cv-00695-GMS, 1:14-cv-00696-GMS, 1:14-cv-00697-GMS, 1:14-cv-00698-GMS (rjb)

2014-06-04

1

No Actions

Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (Kelly, Michael) (Entered: 06/10/2014)

2014-06-10

1

View

DECLARATION of Mailing Regarding Service on Caraco Pharmaceutical Laboratories Ltd. made on June 5, 2014 by AstraZeneca AB. (Attachments: # 1 Exhibit A & B)(Silver, Daniel) (Entered: 06/10/2014)

2014-06-10

1

View

DECLARATION of Mailing Regarding Service on Sun Pharma Global FZE made on June 5, 2014 by AstraZeneca AB. (Attachments: # 1 Exhibit A & B)(Silver, Daniel) (Entered: 06/10/2014)

2014-06-10

1

View

ACKNOWLEDGEMENT OF SERVICE Executed on behalf of Defendant Sun Pharmaceutical Industries Ltd. Acknowledgement filed by AstraZeneca AB. (Silver, Daniel) (Entered: 06/16/2014)

2014-06-16

1

View

STIPULATION and Order Dismissing Defendant Caraco Pharmaceutical Laboratories LTD. by AstraZeneca AB. (Silver, Daniel) (Entered: 06/24/2014)

2014-06-24

1

View

SO ORDERED - re 10 Stipulation filed by AstraZeneca AB; Party Caraco Pharmaceutical Laboratories Ltd. terminated. Signed by Chief Judge Gregory M. Sleet on 6/25/2014. (mdb) (Entered: 06/25/2014)

2014-06-25

1

View

ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against AstraZeneca AB by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Phillips, John) (Entered: 06/26/2014)

2014-06-26

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries, Ltd. for Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Phillips, John) (Entered: 06/26/2014)

2014-06-26

1

View

MOTION for Pro Hac Vice Appearance of Attorney Charles E. Lipsey, James B. Monroe, Robert F. Shaffer and Maximilienne Bishop - filed by AstraZeneca AB, AstraZeneca AB. (Attachments: # 1 Certification of Charles E. Lipsey, # 2 Certification of James B. Monroe, # 3 Certification of Robert F. Shaffer, # 4 Certification of Maximilienne Bishop)(Silver, Daniel) (Entered: 07/14/2014)

2014-07-14

1

View

MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Samuel Park, Maureen L. Rurka, Charles B. Klein, John K. Hsu and Christopher P. Wilson - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Attachments: # 1 Hurst Pro Hac Certification, # 2 Park Pro Hac Certification, # 3 Rurka Pro Hac Certification, # 4 Klein Pro Hac Certification, # 5 Hsu Pro Hac Certification, # 6 Wilson Pro Hac Certification)(Haney, Megan) (Entered: 07/15/2014)

2014-07-15

1

View

ANSWER to 12 Answer to Complaint, Counterclaim AstraZeneca AB's Reply to Sun's Counterclaims by AstraZeneca AB.(Silver, Daniel) (Entered: 07/17/2014)

2014-07-17

1

View

SO ORDERED - re (15 in 1:14-cv-00666-GMS, 13 in 1:14-cv-00667-GMS, 11 in 1:14-cv-00698-GMS, 10 in 1:14-cv-00697-GMS, 11 in 1:14-cv-00664-GMS, 7 in 1:14-cv-00845-GMS, 12 in 1:14-cv-00665-GMS, 10 in 1:14-cv-00695-GMS, 14 in 1:14-cv-00694-GMS) MOTION for Pro Hac Vice Appearance of Attorney Charles E. Lipsey, James B. Monroe, Robert F. Shaffer and Maximilienne Bishop filed by AstraZeneca AB, AstraZeneca AB. Ordered by Judge Gregory M. Sleet on 7/17/2014. Associated Cases: 1:14-cv-00664-GMS et al.(mdb) Modified on 7/17/2014 (mdb).

2014-07-17

1

No Actions

SO ORDERED - re (15 in 1:14-cv-00694-GMS) MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Samuel Park, Maureen L. Rurka, Charles B. Klein, John K. Hsu and Christopher P. Wilson filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., (11 in 1:14-cv-00697-GMS) MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Samuel Park, Maureen L. Rurka, Charles B. Klein, John K. Hsu and Christopher P. Wilson filed by Amneal Pharmaceuticals LLC. Ordered by Judge Gregory M. Sleet on 7/17/2014. (mdb)

2014-07-17

1

No Actions

Pro Hac Vice Attorney Maximilienne Bishop for AstraZeneca AB added for electronic noticing. Associated Cases: 1:14-cv-00664-GMS et al.(dmp, )

2014-07-17

1

No Actions

Pro Hac Vice Attorney Charles E. Lipsey for AstraZeneca AB added for electronic noticing. Associated Cases: 1:14-cv-00664-GMS et al.(dmp, )

2014-07-18

1

No Actions

Pro Hac Vice Attorney James F. Hurst for Amneal Pharmaceuticals LLC,James F. Hurst for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els)

2014-07-22

1

No Actions

Pro Hac Vice Attorney Maureen L. Rurka for Amneal Pharmaceuticals LLC,Maureen L. Rurka for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els)

2014-07-22

1

No Actions

Pro Hac Vice Attorney Charles B. Klein for Amneal Pharmaceuticals LLC,Charles B. Klein for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els)

2014-07-22

1

No Actions

Pro Hac Vice Attorney Charles P. Wilson for Amneal Pharmaceuticals LLC,Charles P. Wilson for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els)

2014-07-22

1

No Actions

Pro Hac Vice Attorney Samuel S. Park for Amneal Pharmaceuticals LLC,Samuel S. Park for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els)

2014-07-22

1

No Actions

Pro Hac Vice Attorney John K. Hsu for Sun Pharma Global FZE added for electronic noticing. (dmp, )

2014-07-28

1

No Actions

NOTICE of Appearance by David A. Bilson on behalf of Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. (Bilson, David) (Entered: 08/26/2014)

2014-08-26

1

View

Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than April 25, 2014. Date of Expiration of Patent: 7,951,400 (November 30, 2028); RE44,186 (July 31, 2023); 8,628,799 (July 13, 2025).Thirty Month Stay Deadline: 1/31/2017. (Silver, Daniel) (Entered: 09/23/2014)

2014-09-23

1

View

ORAL ORDER SCHEDULING A RULE 16.2b CONFERENCE IN COURTROOM 4A: A Rule 16.2b Scheduling Conference has been set in these related matters for Wednesday, October 8, 2014, at 10:00 AM with the Honorable Gregory M. Sleet in Courtroom 4A. The parties shall file a Joint Status Report (see court's website for sample) no later than NOON on Wednesday, October 1, 2014. Ordered by Judge Gregory M. Sleet on 9/23/2014. (ctd)

2014-09-23

1

No Actions

NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests to Sun for the Production of Documents and Things (Nos. 1-15) and (2) Plaintiff's First Set of Interrogatories to Sun (Nos. 1-7) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 09/30/2014)

2014-09-30

1

View

Joint STATUS REPORT by AstraZeneca AB. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Silver, Daniel) (Entered: 10/01/2014)

2014-10-01

1

View

PROPOSED ORDER Scheduling by AstraZeneca AB. (Silver, Daniel) (Entered: 10/01/2014)

2014-10-01

1

View

Remark: Cases are CONSOLIDATED FOR ALL PURPOSES. All future filings, except those involving the pending motions in 14-cv-696 and 14-cv-665, shall be filed in 14-cv-664 ONLY. Case associated with lead case: Create association to 1:14-cv-00664-GMS. Associated Cases: 1:14-cv-00665-GMS et al.(mdb)

2014-10-08

1

No Actions

Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 10/8/2014. Joinder of Parties due 3/6/2015; Amendment of Pleadings due 9/15/2015; Claim Construction Briefing: Opening due 6/26/2015, Answering due 7/24/2015; A Markman Hearing (4 hrs.) is set for 9/25/2015 at 9:30 AM in Courtroom 4A; Fact Discovery to be completed by 10/16/2015; Expert Discovery: Opening Reports due 11/6/2015, Rebuttal Reports due 12/18/2015, Completed by 3/18/2016; Pretrial Order due by 6:00 PM on 8/1/2016; A Pretrial Conference (by telephone, tentatively) is set for 9/7/2016 at 10:00 AM in Chambers; A 10-day Bench Trial is set for 9/19/2016 at 9:00 AM in Courtroom 4A. THESE CASES ARE CONSOLIDATED FOR ALL PURPOSES. Plaintiff's counsel shall file the proposed case management order by 10/17/2014. (Court Reporter Kevin Maurer.) Associated Cases: 1:14-cv-00664-GMS et al.(mdb)

2014-10-08

1

No Actions

Official Transcript of Conference held on 10 08 14 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/5/2014. Redacted Transcript Deadline set for 11/17/2014. Release of Transcript Restriction set for 1/13/2015. (kjm) (Entered: 10/15/2014)

2014-10-15

1

View

ORDER: On or before Monday, November 10, 2014, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, the information requested in the Order. Signed by Judge Mary Pat Thynge on 10/21/14. (cak) (cak). (Entered: 10/21/2014)

2014-10-21

1

View

CORRECTING ENTRY: Added Order to DI 27 in 14-664; DI 27 in 14-665; DI 21 in 14-666; DI 22 in 667; DI 23 in 15-694; DI 19 in 14-695; DI 19 in 14-697; DI 23 in 14-698; DI 17 in 14-845; and DI 17 in 14-1051. Associated Cases: 1:14-cv-00664-GMS et al.(cak)

2014-10-21

1

No Actions

JUDGMENT entered in favor of the plaintiff and against defendant. CASE CLOSED. Signed by Judge Gregory M. Sleet on 2/2/2017. Associated Cases: 1:14-cv-00664-GMS et al.(mdb) (Entered: 02/02/2017)

2017-02-02

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) (Entered: 02/02/2017)

2017-02-02

1

View

Overview

Parties

Defendant

Caraco Pharmaceutical Laboratories Ltd. Follow

Represented By

Sun Pharmaceutical Industries Ltd. Follow

Represented By

Sun Pharma Global FZE Follow

Represented By

Plaintiff

AstraZeneca AB Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 06/03/2014)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 4/25/14. Date of Expiration of Patent: See attached.Thirty Month Stay Deadline: 10/26/2016. (dmp, ) (Entered: 06/03/2014)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE44,186; 7,951,400; 8,628,799;. (dmp, ) (Entered: 06/03/2014)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC, Corporate Parent Zeneca Wilmington Inc. for AstraZeneca AB filed by AstraZeneca AB. (dmp, ) (Entered: 06/03/2014)

No Summons Issued. (dmp, )

Summons Issued with Magistrate Consent Notice attached as to Caraco Pharmaceutical Laboratories Ltd. on 6/3/2014; Sun Pharma Global FZE on 6/3/2014. (rwc)

Summons Reissued with Magistrate Consent Notice attached as to Sun Pharma Global FZE. (rbe)

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:14-cv-00694-GMS, 1:14-cv-00695-GMS, 1:14-cv-00696-GMS, 1:14-cv-00697-GMS, 1:14-cv-00698-GMS (rjb)

Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (Kelly, Michael) (Entered: 06/10/2014)

DECLARATION of Mailing Regarding Service on Caraco Pharmaceutical Laboratories Ltd. made on June 5, 2014 by AstraZeneca AB. (Attachments: # 1 Exhibit A & B)(Silver, Daniel) (Entered: 06/10/2014)

DECLARATION of Mailing Regarding Service on Sun Pharma Global FZE made on June 5, 2014 by AstraZeneca AB. (Attachments: # 1 Exhibit A & B)(Silver, Daniel) (Entered: 06/10/2014)

ACKNOWLEDGEMENT OF SERVICE Executed on behalf of Defendant Sun Pharmaceutical Industries Ltd. Acknowledgement filed by AstraZeneca AB. (Silver, Daniel) (Entered: 06/16/2014)

STIPULATION and Order Dismissing Defendant Caraco Pharmaceutical Laboratories LTD. by AstraZeneca AB. (Silver, Daniel) (Entered: 06/24/2014)

SO ORDERED - re 10 Stipulation filed by AstraZeneca AB; Party Caraco Pharmaceutical Laboratories Ltd. terminated. Signed by Chief Judge Gregory M. Sleet on 6/25/2014. (mdb) (Entered: 06/25/2014)

ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against AstraZeneca AB by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Phillips, John) (Entered: 06/26/2014)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries, Ltd. for Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Phillips, John) (Entered: 06/26/2014)

ANSWER to 12 Answer to Complaint, Counterclaim AstraZeneca AB's Reply to Sun's Counterclaims by AstraZeneca AB.(Silver, Daniel) (Entered: 07/17/2014)

Pro Hac Vice Attorney Maximilienne Bishop for AstraZeneca AB added for electronic noticing. Associated Cases: 1:14-cv-00664-GMS et al.(dmp, )

Pro Hac Vice Attorney Charles E. Lipsey for AstraZeneca AB added for electronic noticing. Associated Cases: 1:14-cv-00664-GMS et al.(dmp, )

Pro Hac Vice Attorney James F. Hurst for Amneal Pharmaceuticals LLC,James F. Hurst for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els)

Pro Hac Vice Attorney Maureen L. Rurka for Amneal Pharmaceuticals LLC,Maureen L. Rurka for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els)

Pro Hac Vice Attorney Charles B. Klein for Amneal Pharmaceuticals LLC,Charles B. Klein for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els)

Pro Hac Vice Attorney Charles P. Wilson for Amneal Pharmaceuticals LLC,Charles P. Wilson for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els)

Pro Hac Vice Attorney Samuel S. Park for Amneal Pharmaceuticals LLC,Samuel S. Park for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els)

Pro Hac Vice Attorney John K. Hsu for Sun Pharma Global FZE added for electronic noticing. (dmp, )

NOTICE of Appearance by David A. Bilson on behalf of Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. (Bilson, David) (Entered: 08/26/2014)

NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests to Sun for the Production of Documents and Things (Nos. 1-15) and (2) Plaintiff's First Set of Interrogatories to Sun (Nos. 1-7) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 09/30/2014)

Joint STATUS REPORT by AstraZeneca AB. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Silver, Daniel) (Entered: 10/01/2014)

PROPOSED ORDER Scheduling by AstraZeneca AB. (Silver, Daniel) (Entered: 10/01/2014)

Remark: Cases are CONSOLIDATED FOR ALL PURPOSES. All future filings, except those involving the pending motions in 14-cv-696 and 14-cv-665, shall be filed in 14-cv-664 ONLY. Case associated with lead case: Create association to 1:14-cv-00664-GMS. Associated Cases: 1:14-cv-00665-GMS et al.(mdb)

CORRECTING ENTRY: Added Order to DI 27 in 14-664; DI 27 in 14-665; DI 21 in 14-666; DI 22 in 667; DI 23 in 15-694; DI 19 in 14-695; DI 19 in 14-697; DI 23 in 14-698; DI 17 in 14-845; and DI 17 in 14-1051. Associated Cases: 1:14-cv-00664-GMS et al.(cak)

JUDGMENT entered in favor of the plaintiff and against defendant. CASE CLOSED. Signed by Judge Gregory M. Sleet on 2/2/2017. Associated Cases: 1:14-cv-00664-GMS et al.(mdb) (Entered: 02/02/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) (Entered: 02/02/2017)

Track Case Updates

Caraco Pharmaceutical Laboratories Ltd.

Sun Pharmaceutical Industries Ltd.

Sun Pharma Global FZE

AstraZeneca AB